Bullboard - Stock Discussion Forum Appili Therapeutics Inc APLIF

Primary Symbol: T.APLI

Healthcare

Appili Therapeutics Inc. is a Canada-based biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. The Company is advancing a diverse range of anti-infectives, including ready-made suspension of metronidazole for the treatment of antimicrobial infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical... see more

Add To Watchlist

TSX:APLI - Post Discussion

Appili Therapeutics Inc > Appili Therapeutics Target $2.75

View:

Post by stochastics1 on Feb 05, 2021 7:18am

Appili Therapeutics Target $2.75

Halifax-based infectious disease drug developer Appili Therapeutics (TSX:APLI) received a coverage initiation from Leede Jones Gable analyst Douglas W. Loe on Wednesday, with the analyst starting the stock off with a “Speculative Buy” rating and $2.75 target price. Loe said Appili’s partnership on a COVID-19 antiviral drug could start generating revenue as early as next year.

Read Full News Release Click Here

391